10-Q quarterly report · filed Oct 23, 2026

BALCHEM CORP (BCPC) Q3 2026 10-Q Quarterly Report

Short answer

BALCHEM CORP (BCPC) filed its Q3 2026 10-Q quarterly report on Oct 23, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $291M (up 8.6% year over year) with net income of $47M.

Q3 2026 key financials · XBRL

Revenue
$291M
+8.6% YoY · +2.3% QoQ
Net income
$47M
+16.0% YoY · +4.7% QoQ
Operating margin
21.5%
Gross margin
36.4%
EPS (diluted)
$1.46
+17.7% YoY · +5.8% QoQ

Source: XBRL data from the BALCHEM CORP (BCPC) Q3 2026 10-Q on SEC EDGAR. USD.

BALCHEM CORP Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Q3 revenue $290.658M, up 8.6% YoY from $267.558M
  • Gross margin 36.4% vs 35.7%; operating margin 21.5% vs 20.4%
  • Best segment: Animal Nutrition & Health revenue $62.990M, up 11.7%; worst growth: Specialty Products, up 4.5% to $37.294M
  • Operating cash flow $156.544M, up 4.9%; cash $66.264M vs $74.570M at December 31, 2025
  • Capital deployment: $71.925M stock repurchases, $40.000M net debt payments, $29.605M capital expenditures and intangible assets
  • Outlook risks: geopolitical tensions, energy and raw material costs, freight costs, shipping volatility, tariffs and macroeconomic conditions

Risk Factors

  • No material changes to risk factors since the December 31, 2025 Form 10-K
  • Key carried-forward risks remain those disclosed in the 2025 Annual Report

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other BALCHEM CORP quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.